Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer – PR Newswire (press release)
Medical Daily |
Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer
PR Newswire (press release) NEW YORK, June 3, 2017 /PRNewswire-USNewswire/ — The immunotherapy drug pembrolizumab—already FDA-approved for other forms of cancer–has been found to be effective in patients with metastatic triple negative breast cancer, according to an … Treatment For Triple Negative Breast Cancer; Immunotherapy Drug Effective In New Trials |
